{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:43:51Z","timestamp":1794959031999,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioblastoma is an aggressive form of brain cancer with well-established patterns of intra-tumoral heterogeneity implicated in treatment resistance and progression. While regional and single cell transcriptomic variations of glioblastoma have been recently resolved, downstream phenotype-level proteomic programs have yet to be assigned across glioblastoma\u2019s hallmark histomorphologic niches. Here, we leverage mass spectrometry to spatially align abundance levels of 4,794 proteins to distinct histologic patterns across 20 patients and propose diverse molecular programs operational within these regional tumor compartments. Using machine learning, we overlay concordant transcriptional information, and define two distinct proteogenomic programs, MYC- and KRAS-axis hereon, that cooperate with hypoxia to produce a tri-dimensional model of intra-tumoral heterogeneity. Moreover, we highlight differential drug sensitivities and relative chemoresistance in glioblastoma cell lines with enhanced KRAS programs. Importantly, these pharmacological differences are less pronounced in transcriptional glioblastoma subgroups suggesting that this model may provide insights for targeting heterogeneity and overcoming therapy resistance.<\/jats:p>","DOI":"10.1038\/s41467-021-27667-w","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T11:02:59Z","timestamp":1641812579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6125-3656","authenticated-orcid":false,"given":"K. H. Brian","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7691-8104","authenticated-orcid":false,"given":"Sandy Che-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihor","family":"Batruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8006-5044","authenticated-orcid":false,"given":"Kevin","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almos","family":"Klekner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Hut\u00f3czki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Koritzinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Richer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugljesa","family":"Djuric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5291-9068","authenticated-orcid":false,"given":"Phedias","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"27667_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-011-0749-4","volume":"107","author":"DR Johnson","year":"2012","unstructured":"Johnson, D. R. & O\u2019Neill, B. P. Glioblastoma survival in the United States before and during the temozolomide era. J. Neurooncol. 107, 359\u2013364 (2012).","journal-title":"J. Neurooncol."},{"key":"27667_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp, R. et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459\u2013466 (2009).","journal-title":"Lancet Oncol."},{"key":"27667_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1126\/science.aaf2666","volume":"360","author":"RB Puchalski","year":"2018","unstructured":"Puchalski, R. B. et al. An anatomic transcriptional atlas of human glioblastoma. Science. 360, 660\u2013663 (2018).","journal-title":"Science."},{"key":"27667_CR4","doi-asserted-by":"publisher","unstructured":"Hambardzumyan, D. & Bergers, G. Glioblastoma: Defining Tumor Niches. vol. 1, https:\/\/doi.org\/10.1016\/j.trecan.2015.10.009 (2015).","DOI":"10.1016\/j.trecan.2015.10.009"},{"key":"27667_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756\u2013760 (2006).","journal-title":"Nature"},{"key":"27667_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","volume":"11","author":"C Calabrese","year":"2007","unstructured":"Calabrese, C. et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 11, 69\u201382 (2007).","journal-title":"Cancer Cell."},{"key":"27667_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RGW Verhaak","year":"2010","unstructured":"Verhaak, R. G. W. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 17, 98\u2013110 (2010).","journal-title":"Cancer Cell."},{"key":"27667_CR8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"R McLendon","year":"2008","unstructured":"McLendon, R. et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008).","journal-title":"Nature"},{"key":"27667_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1158\/1541-7786.MCR-08-0435","volume":"7","author":"S Madhavan","year":"2009","unstructured":"Madhavan, S. et al. Rembrandt: Helping personalized medicine become a reality through integrative translational research. Mol. Cancer Res. 7, 157\u2013167 (2009).","journal-title":"Mol. Cancer Res."},{"key":"27667_CR10","doi-asserted-by":"publisher","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science. 357, eaan2507. https:\/\/doi.org\/10.1126\/science.aan2507 (2017).","DOI":"10.1126\/science.aan2507"},{"key":"27667_CR11","doi-asserted-by":"publisher","unstructured":"Wang, L.-B. et al. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccell.2021.01.006 (2021).","DOI":"10.1016\/j.ccell.2021.01.006"},{"key":"27667_CR12","doi-asserted-by":"publisher","unstructured":"Venteicher, A. S. et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science. 355, eaai8478. https:\/\/doi.org\/10.1126\/science.aai8478 (2017).","DOI":"10.1126\/science.aai8478"},{"key":"27667_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel, C. et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178, 835\u2013849.e21 (2019).","journal-title":"Cell"},{"key":"27667_CR14","doi-asserted-by":"publisher","unstructured":"Eberhart, C. G. & Bar, E. E. Spatial enrichment of cellular states in glioblastoma. Acta Neuropathol. 1\u20133 https:\/\/doi.org\/10.1007\/s00401-020-02165-3 (2020).","DOI":"10.1007\/s00401-020-02165-3"},{"key":"27667_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/noajnl\/vdaa070","volume":"2","author":"KHB Lam","year":"2020","unstructured":"Lam, K. H. B., Valkanas, K., Djuric, U. & Diamandis, P. Unifying models of glioblastoma\u2019s intratumoral heterogeneity. Neuro-Oncol. Adv. 2, 1\u20133 (2020).","journal-title":"Neuro-Oncol. Adv."},{"key":"27667_CR16","first-page":"453","volume":"14","author":"W Wick","year":"2018","unstructured":"Wick, W. & Kessler, T. New glioblastoma heterogeneity atlas - a shared resource. Nature reviews. Neurology 14, 453\u2013454 (2018).","journal-title":"Neurology"},{"key":"27667_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fonc.2019.00482","volume":"9","author":"P Civita","year":"2019","unstructured":"Civita, P. et al. Laser capture microdissection and RNA-Seq analysis: High sensitivity approaches to explain histopathological heterogeneity in human glioblastoma FFPE Archived Tissues. Front. Oncol. 9, 482 (2019).","journal-title":"Front. Oncol."},{"key":"27667_CR18","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.celrep.2017.07.049","volume":"20","author":"E Johansson","year":"2017","unstructured":"Johansson, E. et al. CD44 interacts with HIF-2\u03b1 to modulate the hypoxic phenotype of perinecrotic and perivascular glioma cells. Cell Rep. 20, 1641\u20131653 (2017).","journal-title":"Cell Rep."},{"key":"27667_CR19","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.celrep.2016.05.018","volume":"15","author":"M Mineo","year":"2016","unstructured":"Mineo, M. et al. The Long non-coding RNA HIF1A-AS2 facilitates the maintenance of mesenchymal glioblastoma stem-like cells in hypoxic niches. Cell Rep. 15, 2500\u20132509 (2016).","journal-title":"Cell Rep."},{"key":"27667_CR20","doi-asserted-by":"publisher","unstructured":"Grassi, E. S., Pantazopoulou, V. & Pietras, A. Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma. Oncogene. 1\u201317 https:\/\/doi.org\/10.1038\/s41388-020-1273-9 (2020).","DOI":"10.1038\/s41388-020-1273-9"},{"key":"27667_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13726-w","volume":"10","author":"O Celiku","year":"2019","unstructured":"Celiku, O., Gilbert, M. R. & Lavi, O. Computational modeling demonstrates that glioblastoma cells can survive spatial environmental challenges through exploratory adaptation. Nat. Commun. 10, 1\u201310 (2019).","journal-title":"Nat. Commun."},{"key":"27667_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","volume":"549","author":"HS Venkatesh","year":"2017","unstructured":"Venkatesh, H. S. et al. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature 549, 533\u2013537 (2017).","journal-title":"Nature"},{"key":"27667_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature23000","volume":"547","author":"TE Miller","year":"2017","unstructured":"Miller, T. E. et al. Transcription elongation factors represent in vivo cancer dependencies in glioblastoma. Nature 547, 355\u2013359 (2017).","journal-title":"Nature"},{"key":"27667_CR24","first-page":"2123","volume":"17","author":"L Peng","year":"2019","unstructured":"Peng, L. et al. Distribution of cancer stem cells in two human brain gliomas. Oncol. Lett. 17, 2123\u20132130 (2019).","journal-title":"Oncol. Lett."},{"key":"27667_CR25","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1074\/mcp.RA119.001521","volume":"18","author":"U Djuric","year":"2019","unstructured":"Djuric, U. et al. Defining protein pattern differences among molecular subtypes of diffuse gliomas using mass spectrometry. Mol. Cell. Proteomics. 18, 2029\u20132043 (2019).","journal-title":"Mol. Cell. Proteomics."},{"key":"27667_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2015","unstructured":"Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382\u2013387 (2015).","journal-title":"Nature"},{"key":"27667_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55\u201362 (2016).","journal-title":"Nature"},{"key":"27667_CR28","first-page":"755","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Integrated proteogenomic characterization of human high-grade serous ovarian. Cancer Cell 166, 755\u2013765 (2016).","journal-title":"Cancer Cell"},{"key":"27667_CR29","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1073\/pnas.1219747110","volume":"110","author":"A Sottoriva","year":"2013","unstructured":"Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. U.S.A. 110, 4009\u20134014 (2013).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"27667_CR30","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"Cancer Genome Atlas Research Network.","year":"2015","unstructured":"Cancer Genome Atlas Research Network. et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481\u20132498 (2015).","journal-title":"N. Engl. J. Med."},{"key":"27667_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.stem.2019.11.015","volume":"26","author":"A Bhaduri","year":"2020","unstructured":"Bhaduri, A. et al. Outer radial glia-like cancer stem cells contribute to heterogeneity of glioblastoma. Cell Stem Cell 26, 48\u201363.e6 (2020).","journal-title":"Cell Stem Cell"},{"key":"27667_CR32","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1073\/pnas.1418164112","volume":"112","author":"EC Finger","year":"2015","unstructured":"Finger, E. C. et al. Hypoxic induction of AKAP12 variant 2 shifts PKA-mediated protein phosphorylation to enhance migration and metastasis of melanoma cells. Proc. Natl Acad. Sci. U.S.A. 112, 4441\u20134446 (2015).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"27667_CR33","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","volume":"25","author":"RG Majzner","year":"2019","unstructured":"Majzner, R. G. et al. CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors. Clin. Cancer Res. 25, 2560\u20132574 (2019).","journal-title":"Clin. Cancer Res."},{"key":"27667_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","volume":"580","author":"M Touat","year":"2020","unstructured":"Touat, M. et al. Mechanisms and therapeutic implications of hypermutation in gliomas. Nature 580, 517\u2013523 (2020).","journal-title":"Nature"},{"key":"27667_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/jnen\/nlaa108","volume":"80","author":"N Alsafwani","year":"2021","unstructured":"Alsafwani, N., Alrjoub, M., Djuric, U., Gao, A. & Diamandis, P. Tumor-infiltrating lymphocytes are enriched in nonhypoxic glioblastoma niches. J. Neuropathol. Exp. Neurol. 80, 202\u2013204 (2021).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"27667_CR36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ni967","volume":"4","author":"WK Suh","year":"2003","unstructured":"Suh, W. K. et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4, 899\u2013906 (2003).","journal-title":"Nat. Immunol."},{"key":"27667_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccell.2017.03.005","volume":"31","author":"S Seaman","year":"2017","unstructured":"Seaman, S. et al. Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature. Cancer Cell. 31, 501\u2013515.e8 (2017).","journal-title":"Cancer Cell."},{"key":"27667_CR38","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","volume":"181","author":"E Friebel","year":"2020","unstructured":"Friebel, E. et al. Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes. Cell 181, 1626\u20131642.e20 (2020).","journal-title":"Cell"},{"key":"27667_CR39","doi-asserted-by":"publisher","first-page":"CNS21","DOI":"10.2217\/cns-2017-0037","volume":"7","author":"E Orrego","year":"2018","unstructured":"Orrego, E. et al. Distribution of tumor-infiltrating immune cells in glioblastoma. CNS Oncol. 7, CNS21\u2013CNS21 (2018).","journal-title":"CNS Oncol."},{"key":"27667_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms15080","volume":"8","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth. Nat. Commun. 8, 1\u201317 (2017).","journal-title":"Nat. Commun."},{"key":"27667_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","volume":"170","author":"EY Qin","year":"2017","unstructured":"Qin, E. Y. et al. Neural precursor-derived pleiotrophin mediates subventricular zone invasion by glioma. Cell. 170, 845\u2013859.e19 (2017).","journal-title":"Cell."},{"key":"27667_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-05931-8","volume":"7","author":"A Fujikawa","year":"2017","unstructured":"Fujikawa, A. et al. Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells. Sci. Rep. 7, 1\u201317 (2017).","journal-title":"Sci. Rep."},{"key":"27667_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"27667_CR44","doi-asserted-by":"publisher","unstructured":"Richards, L. M. et al. Gradient of developmental and injury response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nat. Cancer. 1\u201317 https:\/\/doi.org\/10.1038\/s43018-020-00154-9 (2021).","DOI":"10.1038\/s43018-020-00154-9"},{"key":"27667_CR45","doi-asserted-by":"crossref","unstructured":"Wells, C. I. et al. The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification. Int. J. Mol. Sci. 22, 566 (2021).","DOI":"10.3390\/ijms22020566"},{"key":"27667_CR46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","volume":"15","author":"M Lim","year":"2018","unstructured":"Lim, M., Xia, Y., Bettegowda, C. & Weller, M. Current state of immunotherapy for glioblastoma. Nat. Rev. Clin. Oncol. 15, 422\u2013442 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"27667_CR47","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-12-0715","volume":"18","author":"D Loo","year":"2012","unstructured":"Loo, D. et al. Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity. Clin. Cancer Res. 18, 3834\u20133845 (2012).","journal-title":"Clin. Cancer Res."},{"key":"27667_CR48","doi-asserted-by":"publisher","unstructured":"Pine, A. R. et al. Tumor microenvironment is critical for the maintenance of cellular states found in primary glioblastomas. Cancer Discov. CD-20-0057 https:\/\/doi.org\/10.1158\/2159-8290.cd-20-0057 (2020).","DOI":"10.1158\/2159-8290.cd-20-0057"},{"key":"27667_CR49","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao, L. et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell. 184, 5031\u20135052.e26 (2021).","journal-title":"Cell."},{"key":"27667_CR50","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Res. 47, D442\u2013D450 (2019).","journal-title":"Nucleic Acids Res."},{"key":"27667_CR51","doi-asserted-by":"publisher","unstructured":"Lam, B., Leon, A., Djuric, U. & Diamandis, P. RNA dataset to train XGBoost model. Zenodo https:\/\/zenodo.org\/record\/5639569https:\/\/doi.org\/10.5281\/ZENODO.5639569 (2021).","DOI":"10.5281\/ZENODO.5639569"},{"key":"27667_CR52","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinforma.14, 1\u201315 (2013).","DOI":"10.1186\/1471-2105-14-7"},{"key":"27667_CR53","unstructured":"Blighe, K., S Rana, & M. L. Enhanced Volcano: Publication-ready volcano plots with enhanced colouring and labeling. Github (2018)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27667-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27667-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27667-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:24:15Z","timestamp":1669303455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27667-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27667"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27667-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"19 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}